Risk of SDRs Under 3HP and 1HP Regimen for LTBI
NCT04094012
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
490
Enrollment
OTHER
Sponsor class
Conditions
Latent Tuberculosis Infection
Interventions
DRUG:
isoniazid and rifapentine
Sponsor
National Taiwan University Hospital